Please try another search
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of travelers’ diarrhea in adults. Its clinical late-stage investigational development programs include RHB-204, which is in Phase 3 study for pulmonary nontuberculous mycobacteria infections; opaganib (Yeliva), an SK2 selective inhibitor, which has completed Phase 2 study to treat patients with SARS-CoV-2 severe COVID-19 pneumonia, in Phase 2 study to treat advanced unresectable cholangiocarcinoma, and in investigator-sponsored Phase 2 study to treat prostate cancer; RHB-107, which is in Phase 2/3 study to treat outpatients infected with COVID-19 disease, and preclinical evaluation study to treat advanced unresectable cholangiocarcinoma, as well as has completed Phase 2 study to treat gastrointestinal and other solid tumors; and RHB-104, which is in Phase 3 studies for Crohn's disease; RHB-102 (Bekinda) that is in Phase 3 studies for acute gastroenteritis and gastritis. RedHill Biopharma Ltd. was incorporated in 2009 and is headquartered in Tel Aviv, Israel.
Name | Age | Since | Title |
---|---|---|---|
Alessandro E. Della Cha | 58 | 2021 | Independent Director |
Ira N. Kalfus | 61 | 2010 | Member of Advisory Board |
Shmuel Cabilly | 72 | 2019 | Independent Director |
Werner Tschollar | - | - | Member of Advisory Board |
Ran Oren | - | - | Member of Advisory Board |
Thomas Julius Borody | - | - | Member of Advisory Board |
Yechezkel Barenholz | - | - | Member of Advisory Board |
Jerry Rosenblatt | - | - | Member of Advisory Board |
Kenneth Reed | 68 | 2009 | Independent Director |
Abe Schwartz | - | - | Member of Advisory Board |
Matthew Scott Harris | 70 | 2017 | Member of Advisory Board |
Alla Felder | 50 | 2019 | Independent Director |
Ofer Tsimchi | 65 | 2011 | Independent Director |
Eric Swenden | 80 | 2010 | Independent Director |
Dror Ben-Asher | 58 | 2009 | Co-Founder, Chairman & CEO |
Rick D. Scruggs | 64 | 2016 | Chief Commercial Officer, President of RedHill Biopharma Inc. & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review